Using human osteosarcoma, U2OS cells expressing ERβ as a model, Cvoro and colleagues showed that both estradiol and ERβ-selective agonists reduced the activation of 18 pro-inflammatory genes (including TNF-α, IL-6, and CSF2) induced by TNF-α (99). This evidence concerns the gene ESR2 and osteosarcoma.